![Tobias Erfurth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tobias Erfurth
Investor Relations Kontakt bei
SCHOTT PHARMA AG & CO. KGAA
Profil
Tobias Erfurth is currently Director-Investor Relations at Emprise AG and Head-Investor Relations at SCHOTT Pharma AG & Co. KGaA since 2024.
Former roles include Director-Investor Relations at CropEnergies AG and Head-Investor Relations at Symrise AG from 2011 to 2024.
Aktive Positionen von Tobias Erfurth
| Unternehmen | Position | Beginn |
|---|---|---|
| SCHOTT PHARMA AG & CO. KGAA | Investor Relations Kontakt | 30.08.2024 |
Emprise AG
 Emprise AG Information Technology ServicesTechnology Services Provides computer software consulting and systems integration services | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Tobias Erfurth
| Unternehmen | Position | Ende |
|---|---|---|
| SYMRISE AG | Investor Relations Kontakt | 01.08.2024 |
| CROPENERGIES AG | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
45
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
CropEnergies AG
 CropEnergies AG Chemicals: SpecialtyProcess Industries Produces bioethanol and animal feed | Process Industries |
Symrise AG
 Symrise AG Chemicals: SpecialtyProcess Industries Produces fragrances and flavorings for taste, nutrition, health & scents | Process Industries |
Emprise AG
Emprise AG Information Technology ServicesTechnology Services Provides computer software consulting and systems integration services | Technology Services |
SCHOTT Pharma AG & Co. KGaA
 SCHOTT Pharma AG & Co. KGaA Medical SpecialtiesHealth Technology Develops and manufactures ampoules, cartridges, vials, glass and polymer syringes to pharmaceutical & biotech industries | Health Technology |
